DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 54,100 shares, an increase of 14.6% from the December 15th total of 47,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 541.0 days.
DiaSorin Price Performance
Shares of DSRLF stock remained flat at $106.85 during trading hours on Friday. The company’s 50-day moving average price is $107.42 and its 200 day moving average price is $102.76. DiaSorin has a 52-week low of $105.88 and a 52-week high of $108.79.
Analysts Set New Price Targets
Separately, UBS Group downgraded DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What is a support level?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.